• Products
  • Community
  • Markets
  • Brokers
  • More
Get started
  • Markets
  • /Denmark
  • /Stocks
  • /Ideas
Novo Nordisk Stock Chart Fibonacci Analysis 050925Trading Idea 1) Find a FIBO slingshot 2) Check FIBO 61.80% level 3) Entry Point > 411/61.80% Chart time frame: D A) 15 min(1W-3M) B) 1 hr(3M-6M) C) 4 hr(6M-1year) D) 1 day(1-3years) Stock progress: A A) Keep rising over 61.80% resistance B) 61.80% resistance C) 61.80% support D) Hit the bottom E) Hit the top Stocks rise as they rise from support and fall from resistance. Our goal is to find a low support point and enter. It can be referred to as buying at the pullback point. The pullback point can be found with a Fibonacci extension of 61.80%. This is a step to find entry level. 1) Find a triangle (Fibonacci Speed Fan Line) that connects the high (resistance) and low (support) points of the stock in progress, where it is continuously expressed as a Slingshot, 2) and create a Fibonacci extension level for the first rising wave from the start point of slingshot pattern. When the current price goes over 61.80% level , that can be a good entry point, especially if the SMA 100 and 200 curves are gathered together at 61.80%, it is a very good entry point. As a great help, tradingview provides these Fibonacci speed fan lines and extension levels with ease. So if you use the Fibonacci fan line, the extension level, and the SMA 100/200 curve well, you can find an entry point for the stock market. At least you have to enter at this low point to avoid trading failure, and if you are skilled at entering this low point, with fibonacci6180 technique, your reading skill to chart will be greatly improved. If you want to do day trading, please set the time frame to 5 minutes or 15 minutes, and you will see many of the low point of rising stocks. If want to prefer long term range trading, you can set the time frame to 1 hr or 1 day.
OMXCOP:NOVO_B
by fibonacci6180
Genmab 4h longZone + 1st measured move PB. Could potentially go all the way up to the expanding triangle top?
OMXCOP:GMABLong
by BaliShag
Updated
22
Novo Nordisk's The recent drop in Novo Nordisk's stock price is attributed to several factors. A key issue is the company’s struggle to meet the surging demand for its weight-loss drugs, such as Wegovy. Although demand remains strong, investors are concerned about Novo Nordisk's ability to scale up production and deliveries, which is creating downward pressure on the stock. Additionally, some recent financial results failed to meet Wall Street expectations. Despite revenue growth in key product categories, overall revenues in some reports came in below forecasts. This underperformance has contributed to a negative investor sentiment. However, analysts emphasize that Novo Nordisk's core products remain in high demand, and the company has significant long-term growth potential if it addresses its supply chain and production challenges
OMXCOP:NOVO_BLong
by ForexCompany
Updated
NVO absolutely sweet levelThis downturn is attributed to disappointing clinical trial results for some of its drugs and concerns over potential tariffs affecting Denmark. Additionally, competition from Eli Lilly's successful weight-loss drug trials has impacted investor confidence. ​ Despite these challenges, analysts note that Novo Nordisk maintains strong fundamentals and a positive long-term outlook, particularly in its core areas of diabetes and obesity treatments.
OMXCOP:NOVO_BLong
by TMEW
Looking kind of LongAfter a really red day for Maersk it reached the main lower trendline and right away bounced back up. I will first see if the price respects the lower main trend and the be looking for a good Long position for the coming days until it reaches the upper trendline on the lower timeline. So far so good.. share you thoughts!
OMXCOP:MAERSK_BLong
by BlueKeld
Updated
Maersk keeps following trend-line, potential short position.Right after the latest Ex-day for dividends it breached the lower trend-line, but worked its way back to it. Yesterday it hit the roof of the upper trend-line and MACD switched to bearish. I will be looking for a short position and expecting a low price around 11200 DK. Share your thoughts, maybe I am missing something big?
OMXCOP:MAERSK_BShort
by BlueKeld
Updated
Short-term idea for upcoming days after Ex-day of DevidendsI will be looking for the passing of the short-term trendline for a short-position tomorrow on Ex-day. My MACD-signal has flipped and yesterday ended right before a potential breakout or Head and Shoulders. Downward trend were confirmed March 14th and has been respected three times already. If continued we could expect price down to 11500 DKK. This is my first printed "idea" on TradingView and in general, take this with a pinch of salt. Please share your thoughts and counter-ideas if any!
OMXCOP:MAERSK_BShort
by BlueKeld
Updated
11
A.P. Møller – Mærsk A/S Bullish Sentiment OMXCOP:MAERSK_A is approaching a major supply zone around 12,800–13,200 DKK, which has previously acted as strong resistance. The stock has been forming higher lows, respecting a long-term ascending trendline, indicating overall bullish structure unless that trendline is broken. In the short term, a W-pattern is forming, indicating bullish momentum towards the supply zone. However, there is a risk of forming a Head and Shoulders pattern, which would be bearish if confirmed. It is also important to note that after the dividend payment, a price drop is expected, possibly due to the adjustment of share price post-dividend distribution. The company continues to beat earnings and increased their dividend payout. Recent news suggests a strong partnership with DP World to expand maritime services in Brazil, which could enhance long-term revenue stability. Bullish Scenario: A break and close above 13,200 DKK with strong volume would confirm further upside potential. Bearish Scenario: If resistance holds and a Head & Shoulders pattern forms, expect a drop toward 10,950 DKK or lower after dividend payments.
OMXCOP:MAERSK_ALong
by Gxbee
11
BAVARIAN NORDIC BAVA LARGE ASCENDING TRIANGLE FORMATIONHello Traders, Here is my chart idea for Bavarian Nordic. This idea is solely based on me looking at the chart formation and no research has been done into the companies financials, potential upcoming vaccines or anything like that. The price has been going sideways inside a large ascending triangle for about 22 years now and price movement still looks to be corrective waves not impulsive waves. It looks like the price wants to come down to the bottom trendline and bounce from there. This would also print a low, oversold value on the monthly RSI. On the weekly chart it looks like the price has just broke down from a head and shoulders. Lets see what happens.
OMXCOP:BAVA
by WickHunter
Gubra bullish from hereEW and trendlines indicates further increase from here.
OMXCOP:GUBRA
by jespergarm
DFDS bearish target hit -> bottom?As shown on an older chart, this was the target for the down trend.. Symmetry + ab=cd reached at channel low and a zone. 54% to the first upside target! Let's go. SL might be too optimistic, but I'm willing to try a few times. Would be f'ing epic :D /edit.. There's a minor first target at gap close at 130
OMXCOP:DFDSLong
by BaliShag
NOVO buyAny break below 810 is a buy. Novo has a lot of upside still left
OMXCOP:NOVO_BLong
by shiftpark
Updated
55
Solar.eu searching for the bottomAnalyzing RSI divergence, EW Solar.eu seems to be nearing the bottom. Healthy economy. The stock is expected to bottom at around 250 this summer. Then it should be good buy
OMXCOP:SOLAR_B
by jespergarm
Novo is going to 480. Wait for it!OMXCOP:NOVO_B Is declining to 480. I think that will be a good price to buy. It has a lot of bad news ahead. But this bad news is not that bad. So see you at 480!
OMXCOP:NOVO_B
by sadegh3783
Updated
11
Last chance for DNORD at this lvl - 4hI have nothing below, so if this doesn't hold I'd suggest it'll continue to at least 175 DKK. I don't trade harmonic patterns any more and haven't got a clue on their win rate these days, but it is a nice bat pattern too ;) Haven't got too much trust in this lvl, but I thought I'd share it since there's a decent drop to the next area of interest.
OMXCOP:DNORDLong
by BaliShag
Vestas turning bullish Given strong divergence on RSI, correlation on wave extensions, high volume below and EW count the target for the earnings date 5. feb is about 90. From there Vestas is expected to turn bullish. Beware that current P/E is about 250 There is some correlation to the Ørsted count
OMXCOP:VWSLong
by jespergarm
Ørsted expected to be bullish from hereIt seems that Ørsted has completed the correction and now will start a bullish move during from here. There is missing volume at 500 and it is expected that this area will be reached during 2025. Earnings coming up soon.
OMXCOP:ORSTEDLong
by jespergarm
MAERSK - End of roadIn the short term, very high selling pressure. In the long term, it looks like there is a plenty of space upward.
OMXCOP:MAERSK_BLong
by EmreSrn
NOVO has developed an H&S formationAs others have also mentioned on Trading View, NOVO has developed an H&S formation. The formation is to some extent supported by volume. Volume should be large when forming the left shoulder 1, as well as when forming the head 2, and when the price goes down at the right shoulder 4, but when forming the right shoulder the volume should be low 3. It is not. Since May, the volume balance has been negative, i.e. high volume at the price bottom and low volume at the price peak. At 794, there will be a significant break of 3%, especially if it is supported by high volume. There is no significant break yet. The object is heading towards 629. An H&S formation is a reversal formation. NOVO has been in a bullish trend, according to MA. However, the price is now below SMA 200. The price momentum indicators go from sell to buy within a month on Trading View. The price is well below a red cloud in Ichimocu. It is not possible to say now whether we will have a significant break down or whether the price will recover. The forecast will depend on this. Fundamentally, analysts are predominantly positive about the stock. Many companies would like to enter the obesity market, but there are far from good results in a phase 1 study to a finished drug, if it becomes a drug at all. Disclaimer: I have a relatively large position in the stock, which I bought when the shares plunged during the covid19 epidemic. I have sold 1/4 share when the price had tripled, so I am thinking of sitting still now even in the face of the technical picture - I am long. In the past, price has fluctuated between two pivot lines at times. Then I have swing traded NOVO. NB: Remember you must do your own research and assessment before buying and selling.
OMXCOP:NOVO_B
by scorpiris
Updated
11
NOVO - Short term targetSupport Resistance Weekly support works Wave We expect a potential correction aligning with Fibonacci levels RSI - No reversal signal yet Daily - Oversold Weekly - Oversold MACD - No reversal signal yet Daily - Sell histograms is growing Weekly - Sell histograms is growing Opening price 625 Take profit 1 660 Take Profit 2 692 Stop loss 584
OMXCOP:NOVO_BLong
by EmreSrn
Novo Nordisk hit my target this week and I have started to buy The head and shoulders pattern successfully played out, with OMXCOP:NOVO_B reaching my full target at 670. Check out my original post: The stock experienced a significant drop, falling as much as 27% on the Friday before Christmas. This was triggered by test results for their obesity drug, CagriSema, which showed patient weight loss of 22.7% - below the anticipated 25%. I believe this reaction is an overcorrection and have taken advantage of this rare opportunity to purchase OMXCOP:NOVO_B , first at 680 and again at 600. I now plan to hold patiently, expecting Novo Nordisk to reach new all-time highs in the coming years.
OMXCOP:NOVO_BLong
by madsroland
Novo completely oversold🐂 Trade Idea: Long - NOVO 🔥 Account Risk: 20.00% 📈 Recommended Product: Stock 🔍 Entry: +/- 750.00 🐿 DCA: No 😫 Stop-Loss: 675.00 🎯 Take-Profit #1: 1,000.00 (50%) 🎯 Trail Rest: Yes 🚨🚨🚨 Important: Don’t forget to always wait for strong confirmation once possible entry zone is reached. Trade ideas don’t work all the time no matter how good they look. Do not get a victim of FOMO, there is always another trade idea waiting. 🚨🚨🚨 If you like what you see don’t forget to leave a comment 💬 or smash that like ❤️ button! — Novo Nordisk is completely oversold (in fear of RFK) and so is the rest of the Pharma sector as well. Nevertheless, Novo is still printing money and trial results for a new product should come in end 24 or beginning 25 for the oral version of the weight loss drug. The fear over political decisions in the US should be used to buy the Pharma sector. For me, it is Novo and Regeneron. — Disclaimer & Disclosures pursuant to §34b WpHG The trades shown here related to stocks, cryptos, commodities, ETFs and funds are always subject to risks. All texts as well as the notes and information do not constitute investment advice or recommendations. They have been taken from publicly available sources to the best of our knowledge and belief. All information provided (all thoughts, forecasts, comments, hints, advice, stop loss, take profit, etc.) are for educational and private entertainment purposes only. Nevertheless, no liability can be assumed for the correctness in each individual case. Should visitors to this site adopt the content provided as their own or follow any advice given, they act on their own responsibility.
OMXCOP:NOVO_BLong
by LGNDRY-Capital
Updated
22
Orsted daily bottomLook for signs of reversal between 300-325. AB=CD to possible channel bottom/doubling of earlier channel and zone.
OMXCOP:ORSTEDLong
by BaliShag
11223344556677889910101111121213131414151516161717181819192020
…999999

Select market data provided by ICE Data services. Select reference data provided by FactSet. Copyright © 2025 FactSet Research Systems Inc.© 2025 TradingView, Inc.

More than a product
  • Supercharts
Screeners
  • Stocks
  • ETFs
  • Bonds
  • Crypto coins
  • Crypto pairs
  • CEX pairs
  • DEX pairs
  • Pine
Heatmaps
  • Stocks
  • ETFs
  • Crypto
Calendars
  • Economic
  • Earnings
  • Dividends
More products
  • Yield curves
  • Options
  • News Flow
  • Pine Script®
  • Sparks
Apps
  • Mobile
  • Desktop
Tools & subscriptions
  • Features
  • Pricing
  • Market data
Special offers
  • CME Group futures
  • Eurex futures
  • US stocks bundle
About company
  • Who we are
  • Manifesto
  • Athletes
  • Blog
  • Careers
  • Media kit
Merch
  • TradingView store
  • Tarot cards for traders
Policies & security
  • Terms of Use
  • Disclaimer
  • Privacy Policy
  • Cookies Policy
  • Accessibility Statement
  • Security vulnerability
  • Status page
Community
  • Social network
  • Wall of Love
  • Refer a friend
  • House Rules
  • Moderators
Ideas
  • Trading
  • Education
  • Editors' picks
Pine Script
  • Indicators & strategies
  • Wizards
  • Freelancers
Business solutions
  • Widgets
  • Charting libraries
  • Lightweight Charts™
  • Advanced Charts
  • Trading Platform
Growth opportunities
  • Advertising
  • Brokerage integration
  • Partner program
  • Education program
Look FirstLook First